RAP
Click for more information
0.00% 20.5¢ resapp health limited

Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-20

  1. BWinter
    2,623 Posts.
    lightbulb Created with Sketch. 307
    clock Created with Sketch.
    30/10/18
    09:54
    Post #: 36309049
    Results for pneumonia and bronchiolitis were less than 70% at this stage andsubmission (FDA) for these diseases will occur in a second phase.
    RAP Price at posting: 22.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.